The Food and Drug Administration (FDA) has recently approved the expanded use of Xolair, a medication primarily used for treating...
Introducing a New Sub Category in the PENTAWARDS 2024 Competition to Honor CBD Products The PENTAWARDS, one of the most...
An Analysis of THCA, Interstate Sales, and the Impact on Oregon The legalization of cannabis has been a hot topic...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
Cannabidiol (CBD) has been gaining popularity in recent years for its potential therapeutic benefits in treating a variety of health...
Unveiling the Therapeutic Potentials of Plants: A Journey into Medicinal Marvels Plants have been an integral part of human civilization...
Bioretec Ltd, a leading medical technology company specializing in bioabsorbable implants, has recently released its Financial Statements Bulletin for the...
Activation of the cardiac α-myosin heavy chain (α-MHC) gene editing has emerged as a promising approach to induce positive inotropy...
The field of regenerative medicine holds great promise for the development of novel therapies to treat a wide range of...
Florida House Panel Moves Forward with Legislation to Limit Hemp Cannabinoids In a move that has sparked controversy and debate,...
The Impact of Tau Depletion in Human Neurons on Aβ-Driven Toxicity: Insights from Molecular Psychiatry Alzheimer’s disease (AD) is a...
Title: Unveiling the Role of Neurofibromin 1 in Regulating Metabolic Balance and Notch-Dependent Quiescence of Murine Juvenile Myogenic Progenitors Introduction:...
Federal Scientists Confirm Medicinal Benefits of Weed and Support Reclassification In a groundbreaking development, federal scientists have confirmed the medicinal...
CBD gummies have gained significant popularity in recent years, thanks to their potential health benefits and ease of consumption. These...
Neurona Therapeutics, a biotechnology company focused on developing cell therapies for neurological disorders, has recently announced securing $120 million in...
